Financials

  • Market Capitalization 7.76 M
  • Employee 6
  • Founded 2016
  • CEO N/A
  • Website www.alzamend.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZMXG7M8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4802
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
5.77 USD-0.17%+0.35%+0.35%-6.94%8.43 M USD
4806
SNGX
Soligenix, Inc. - Common Stock
0.38 USD0.00%-7.32%0.00%-66.37%8.27 M USD
4821
ACXP
Acurx Pharmaceuticals, Inc. - Common Stock
1.41 USD-2.76%-2.76%-2.76%-26.56%7.43 M USD
4822
ENSC
Ensysce Biosciences, Inc. - Common Stock
0.38 USD-2.56%+2.70%+52.00%-0.65%7.39 M USD

Notizie